5-Methyl-2-Pyrazinecarboxylic Acid CAS 5521-55-1 Purity >99.0% (HPLC)

Short Description:

Name: 5-Methyl-2-Pyrazinecarboxylic Acid

Synonyms: 5-Methylpyrazine-2-Carboxylic Acid

CAS: 5521-55-1

Purity: >99.0% (HPLC)

Appearance: Off-White Crystallized Powder

High Quality, Commercial Production

E-Mail: alvin@ruifuchem.com

Send email to us

Product Detail

Product Tags

Description:

Shanghai Ruifu Chemical Co., Ltd. is the leading manufacturer and supplier of 5-Methyl-2-Pyrazinecarboxylic Acid (CAS: 5521-55-1) with high quality. We can provide COA, worldwide delivery, small and bulk quantities available. Please contact: alvin@ruifuchem.com

Chemical Properties:

Chemical Name	5-Methyl-2-Pyrazinecarboxylic Acid
Synonyms	5-Methylpyrazine-2-Carboxylic Acid
CAS Number	5521-55-1
CAT Number	RF-PI2146
Stock Status	In Stock, Production Capacity 20 Tons/Month
Molecular Formula	C6H6N2O2
Molecular Weight	138.12
Brand	Ruifu Chemical

Specifications:

Item	Specifications
Appearance	Off-White Crystallized Powder
Purity / Analysis Method	>99.0% (HPLC)
Melting Point	164.0~168.0℃
Water (by Karl Fischer)	<0.50%
A Single Impurity	<0.50%
Total Impurities	<1.00%
Proton NMR Spectrum	Conforms to Structure
Test Standard	Enterprise Standard
Usage	Pharmaceutical Intermediate; Acipimox Intermediate

Package & Storage:

Package: Bottle, Aluminium foil bag, 25kg/Cardboard Drum, or according to customer's requirement

Storage Condition: Store in sealed containers at cool and dry place; Protect from light and moisture

Advantages:

FAQ:

Application:

5-Methyl-2-Pyrazinecarboxylic Acid (CAS: 5521-55-1) is an important pharmaceutical intermediate, is mainly used for Acipimox intermediate. Acipimox is a potent long-acting antilipolytic nicotinic acid (NA) analog. Like nicotinic acid, acipimox lowers lipids effectively, but unlike nicotinic acid, acipimox is longer acting and therefore much less prone to produce free fatty acid rebounding. Acipimox is recommended as a lipid-lowering agent to treat hyperlipidemia in patients with noninsulin dependent diabetes mellitus. Acipimox is a hypolipidemic agent related to nicotinic acid with pronounced, longlasting antilipolytic activity. In addition to its lipid lowering activity, it produces a beneficial elevation of the anti-atherogenic high density lipoprotein subfraction, HDL2.